Sigma Pharmaceuticals Limited (ASX:SIP) was the S&P/ASX 200’s top performing stock in the 2011 calendar year with its share price jumping 99 per cent in the twelve month period.
The drug manufacturer moved out of the red last year, posting a profit on the back of an improved operating performance and lower interest costs.
The second best performing stock was Iluka Resources Limited (ASX:ILU), up 68 per cent in 2011, followed by Aurora Oil and Gas Limited (ASX:AUT), rising 51 per cent, and Mesoblast Limited (ASX:MSB) lifting 48 per cent.
Over 2011 Beach Energy Limited’s (ASX:BPT) share price gained 42 per cent and Regis Resources Limited (ASX:RRL) increased 41 per cent.
Sigma Pharmaceuticals finished last year at $0.55.
In the first half of the 2012 financial year Sigma Pharmaceuticals rebounded from an interim net loss to a net profit of $26.65 million.
